As such, the combination of altered lipid metabolism as seen through increased LDL combined with LPS/TLR-4 mediated oxidization, worsens dyslipidemia leading to more severe associated clinical sequelae (Figure 2). The gene discussed is TLR4; the disease is metabolic syndrome.